September 9, 2015 News by Patricia Silva, PhD Smoking Can Accelerate Disease Progression in Patients with Multiple Sclerosis A new study entitled āEffect of Smoking Cessation on Multiple Sclerosis Prognosisā recently revealed that smoking by patients with multiple sclerosis (MS) postĀ diagnosis accelerates their disease progression course. The study was published in the journal JAMA Neurology and was led by researchers at the…
September 9, 2015 News by Patricia Inacio, PhD Discovery of Mechanism That “Guides” Immune System Cells to Injury Sites Could Benefit MS Research In a new study entitled āNeutrophil trails guide influenza-specific CD8+ T cells in the airways,ā researchers uncovered a key mechanism mediated by neutrophils that guides immune system cells to the site of an injury or infection. Moreover, this mechanism is crucial for immune cells to function properly…
September 8, 2015 News by Patricia Silva, PhD Mental Visual Imagery Strategy Can Improve Neuropsychological Functions in RRMS Patients A new study published in the journal Restorative Neurology and Neuroscience revealed that multiple sclerosis (MS) patients with relapsing-remitting forms of the disease can improve specific neuropsychological functions through a mental visual imagery strategy. The study was led by researchers at the University of Strasbourg and the…
September 8, 2015 News by Maureen Newman New Genetic Risk Factors for Multiple Sclerosis Identified in Study Two new risk factors for multiple sclerosis have been identified by a research group at the Wellcome Trust Centre for Human Genetics at the University of Oxford in the United Kingdom. Led by Dr. Loukas Moutsianas, the team discovered that having HLA-DQA1*01:01āHLA-DRB1*15:01 and HLA-DQB1*03:01āHLA-DQB1*03:02 gene allele…
September 7, 2015 News by admin New Study Unravels How Myelin is Repaired, May Suggest New MS Treatments Japanese scientists have discovered new information about howĀ the myelin sheath is repaired following damage. Myelin is a fatty substance that wraps around nerve cells and helps them to conduct impulses. The researchĀ could have major implications for how multiple sclerosis is understood and even treated.Ā The study, titled “Inactivation…
September 4, 2015 News by Marta Silva Mylan Confirms Continued Patent Proceedings Concerning MS Therapy Copaxone According toĀ a press release from Mylan N.V., the U.S. Patent and Trademark Office (PTO) has issuedĀ an inter partes review (IPR) proceeding on all claims against a third Copaxone patent for the 40 mg/mL (U.S. Patent No. 8,969,302) formulationĀ by Yeda Research & Development Co., Ltd.
September 3, 2015 News by admin Biomarkers of Early MS and Overactive Bladder Identified in New Study Researchers at theĀ University of Athens Medical School in GreeceĀ have found that people with early stage multiple sclerosis (MS) and overactive bladderĀ (OAB) have reductions in brain serotoninĀ and a stress-related hormone, cortisol. Serotonin is a chemical that helps nerve cells to communicate. The study, titled “Neurochemical and…
September 2, 2015 News by Patricia Silva, PhD Obstructive Sleep Apnea Found To Contribute to BloodāBrain Barrier Breakdown Experienced By MS Patients In a recent study published in the Journal of Neuroimaging, a team of researchers from the UCLA have reported the first evidence that obstructive sleep apnea contributes to a breakdown of the bloodābrain barrier, which plays an important role in protecting brain tissue. The findings are significant for…
September 1, 2015 News by Patricia Inacio, PhD Exclusive Breastfeeding Does Not Increase Women’s Risk for Multiple Sclerosis Relapse In a new study entitled āExclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses,ā researchersĀ investigated how breastfeeding impacts risk for disease relapse in women with multiple sclerosis. The study was published in the journal JAMA Neurology. Around 20 to 30% of women with…